You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
Cisplatin is a potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in apoptosis. The compound has also been shown to induce apoptosis through caspase-3 activation and XIAP expression. Also shown to cause immunosuppression which is thought to be followed by an increase in the host immune response. Platinated DNA adducts also enhance poisoning of DNA topoisomerase I by camptothecin (sc-200871). Cisplatin was the first member of a class of anticancer drugs, which now include carboplatin (sc-202093) and oxaliplatin (sc-202270), that form DNA adducts resulting in apoptosis; however, these molecules also bind other biological molecules such as enzymes which might play a role in their mechanism of action.
1. Bagasra, O., et al. 1985. Cancer Immunol. Immunother. 19: 142-147. PMID: 3157438
2. Bose, R.N. 2002. Mini Rev Med Chem. 2: 103-111. PMID: 12370072
3. Siddik, Z.H. 2003. Oncogene. 22: 7265-7279. PMID: 14576837
4. van Waardenburg, R.C., et al. 2004. J. Biol. Chem. 279: 54502-54509. PMID: 15471886
See how others have used Cisplatin. Click on the entry to view the PubMed entry .
PMID: # 31374291 Li, X.|He, S.|Tian, Y.|Weiss, RM.|Martin, DT.| et al. 2019. Cell. Signal. 63: 109381.
PMID: # 29620162 Yang, X. et al. 2018. Int. J. Oncol. 52: 2021-2030.
PMID: # 29106395 2018. Lab. Invest. 98: 63-78.
PMID: # 28265008 Liu, CW. et al. 2017. Mol. Cancer Ther. 16: 1421-1434.
PMID: # 28692634 Westhoff, GL.|Chen, Y.|Teng, NNH.| et al. 2017. Int. J. Gynecol. Cancer. 27: 1602-1609.
PMID: # 29267289 Chen, Y. et al. 2017. PLoS ONE. 12: e0187222.
PMID: # 29132253 İnci, D. et al. 2017. J. Biomol. Struct. Dyn. 1-24.
PMID: # 28567715 Zhao, H. et al. 2017. Cell Oncol (Dordr). 40: 357-365.
PMID: # 28602975 Kollareddy, M.|Sherrard, A.|Park, JH.|Szemes, M.|Gallacher, K.|Melegh, Z.|Oltean, S.|Michaelis, M.|Cinatl, J.|Kaidi, A.|Malik, K.| et al. 2017. Cancer Lett. 403: 74-85.
PMID: # 28339648 Pendergraft, SS. et al. 2017. Biol. Reprod. 96: 720-732.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.